There are 2789 resources available
1868P - Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London
Presenter: Matthaios Kapiris
Session: ePoster Display
1869TiP - A phase II, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select HER2-expressing solid tumors (DESTINY-PanTumor02)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
1870TiP - Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
Presenter: Charles Rudin
Session: ePoster Display
1871TiP - PLATON – “Platform for Analyzing Targetable Tumor Mutations”: A pilot study
Presenter: Arndt Vogel
Session: ePoster Display
1850P - Communication patterns and cascade testing among pathogenic variant carriers
Presenter: Dione Aguilar
Session: ePoster Display
1851P - Introduction of a G8 screening programme for older cancer patients
Presenter: Michelle Hannan
Session: ePoster Display
1853P - The estimated cancer risks associated with being a carrier for an ATM gene mutation among UK Biobank population
Presenter: Pimkhuan Kamnerdsupaphon
Session: ePoster Display
1854P - Multicentric, comparative, retrospective study on the safety and efficacy of conventional chemotherapy in cirrhotic patients with gastrointestinal cancer
Presenter: Massih Ningarhari
Session: ePoster Display
1855P - Logistic and documentary factors influencing reasonable tumorboard decisions
Presenter: Lars Galonska
Session: ePoster Display
1856P - Electronic informed consent: The need to redesign the consent process for the digital era
Presenter: Celeste Cagnazzo
Session: ePoster Display